International Team Hematology

CCRI’s first international research team is led by Prof George Vassiliou from the Stem Cell Institute, Cambridge, UK. It will deliver research in the Haematological Malignancies focus area under the Translational Cancer Research direction. The team started working in March 2021 and will receive €1,200,000 in funding from CCRI to carry out its work. The aim of establishing the ITL Haematology Group is to facilitate knowledge transfer and bridge collaboration between CCRI and the Cambridge Stem Cell Institute. The group consists of the deputy group leader, a postdoctoral researcher and a research assistant.
hematology 3

Areas of Research

Generic Screens

Application of genetic screens to identify and investigate genetic vulnerabilities of acute myeloid leukaemia and related cancers in order to develop new therapeutic approaches

Mouse Models

Generation and study of bespoke mouse models of somatic mutation drivers of myeloid malignancies, in order to define their molecular, genomic and phenotypic effects on haemopoietic stem and progenitor cells

Detect and Track

Detection and tracking of the evolution of clonal haematopoiesis in healthy individuals, in order to understand the factors involved in leukaemic progression and develop new approaches for early detection.

What we do

Integrating expertise from four pioneering research fields

The Vassiliou Group seeks to understand the cell-autonomous and cell-non-autonomous processes involved in transformation of normal to leukaemic haemopoietic stem cells and to identify genetic vulnerabilities of myeloid malignancies that can be exploited as targets of novel anti-leukaemic therapies. 

diagnostic lab sampling
diagnostic lab case gallery 4
Scroll to Top